Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-09

Clinical Trial Update: Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema) [Phase 3]

View source ↗

Summary

A Phase 3 Japanese safety study of VEGF Trap-Eye for diabetic macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VEGF Trap-Eye (aflibercept)

Snippet

Sponsor: Bayer | Conditions: Macular Edema | Phase 3 | Status: COMPLETED